Company Overview

About the Company

研究团队组建于2013年,定位于干细胞领域的全产业链研发和iPSC药物孵化平台,致力于以iPSC为底层架构的基础研究、药物开发和临床应用, 包括iPSC与再生医学、干细胞肿瘤药物开发、阿尔茨海默病药物、关节药物等生物医学领域,是全球iPSC源细胞药物开发的*。公司主营业务:提供iPSC母细胞株、iMSC细胞、专利授权、iPSC-iMSC分化工艺授权、品控等全案培养服务体系;诱导多能干细胞向间充质干细胞、免疫细胞、血管内皮祖细胞等细胞的定向分化;自体宫内膜干细胞、肿瘤疫苗、细胞存储、重塑体研发应用、相关科研试剂等,与全国各地医学院、 医疗机构、医药企业进行深度合作。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100万(元)
Legal Representative: 王建安
Date Established:
Credit Code: 91440118MA9YB8276K
Registered Address: 广州市黄埔区光谱中路11号3栋13层04单元

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates